Apolipoprotein B (APOB)-containing very LDL (VLDL) production, secretion, and clearance by hepatocytes is a central determinant of hepatic and circulating lipid levels. Impairment of any of the aforementioned processes is associated with the development of multiple diseases. Despite the discovery of genes and processes that govern hepatic VLDL metabolism, our understanding of the different mechanistic steps involved is far from complete. An impediment to these studies is the lack of tractable hepatocyte-based systems to interrogate and follow APOB in cells, which the current study addresses.


You can read the full story here!

Share this message

Latest news Medical Biochemistry Amsterdam

By duda-wsm April 24, 2026
The yearly AGEM awards were announced: Sebastian Hendrix will receive the AGEM Talent grant which will allow him to develop his project on MASLD. The AGEM innovation grant to study regulation of NPC1 was awarded to team ACHILLES consisting of Klevis Ndoj, Marion Brands, Georges Janssens, and Noam Zelcer.
By duda-wsm March 6, 2026
Cytokine specificity in macrophages: JAK-STAT and beyond
Show More